PHIL.MI
Price:
$23.2
Market Cap:
$670.39M
Philogen S.p.A., a biotechnology company, develops drugs for oncology and chronic inflammatory diseases. It is developing Nidlegy, a combination of the immunocytokines L19IL2 and L19TNF developed intralesional treatment for locoregional melanoma and non-melanoma skin cancers; Fibromun, a human immunomodulatory product consisting of L19 antibody and TNF to treat soft tissue sarcoma, leiomyosarcoma, and glioma; and Darleukin (L19IL2), a human immunostimulatory product consisting of the human L19 antibody fused to the human cytokine interleukin-2 (IL2), which is in phase II clinical trial for the treatment of non-small cell lung cancer. The company is also developing Dodekin, a human immunostim...[Read more]
Industry
Biotechnology
IPO Date
2021-03-03
Stock Exchange
MIL
Ticker
PHIL.MI
According to Philogen S.p.A.’s latest financial reports and current stock price. The company's current ROE is 34.72%. This represents a change of 333.80% compared to the average of 8.00% of the last 4 quarters.
The mean historical ROE of Philogen S.p.A. over the last ten years is -0.07%. The current 34.72% ROE has changed -52237.26% with respect to the historical average. Over the past ten years (40 quarters), PHIL.MI's ROE was at its highest in in the September 2024 quarter at 21.93%. The ROE was at its lowest in in the March 2024 quarter at -10.23%.
Average
-0.07%
Median
-1.73%
Minimum
-23.86%
Maximum
32.66%
Discovering the peaks and valleys of Philogen S.p.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 37.64%
Maximum Annual ROE = 32.66%
Minimum Annual Increase = -1271.05%
Minimum Annual ROE = -23.86%
| Year | ROE | Change |
|---|---|---|
| 2024 | 32.66% | -580.29% |
| 2023 | -6.80% | 23.88% |
| 2022 | -5.49% | -63.31% |
| 2021 | -14.96% | -37.29% |
| 2020 | -23.86% | -1271.05% |
| 2019 | 2.04% | -77.85% |
| 2018 | 9.20% | 37.64% |
The current ROE of Philogen S.p.A. (PHIL.MI) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
6.79%
5-year avg
-3.69%
10-year avg
-0.07%
Philogen S.p.A.’s ROE is less than Safilo Group S.p.A. (11.40%), less than Pharmanutra S.p.A. (27.48%), less than EL.En. S.p.A. (19.00%), less than Arterra Bioscience (16.50%), greater than Ulisse Biomed S.p.A. (-5.30%), less than Otofarma S.p.A. (0%), greater than EuKedos S.p.A. (-3.91%),
| Company | ROE | Market cap |
|---|---|---|
| 11.40% | $746.54M | |
| 27.48% | $512.40M | |
| 19.00% | $1.05B | |
| 16.50% | $20.25M | |
| -5.30% | $19.64M | |
| 0% | $30.45M | |
| -3.91% | $16.37M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Philogen S.p.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Philogen S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Philogen S.p.A.'s ROE?
How is the ROE calculated for Philogen S.p.A. (PHIL.MI)?
What is the highest ROE for Philogen S.p.A. (PHIL.MI)?
What is the 3-year average ROE for Philogen S.p.A. (PHIL.MI)?
What is the 5-year average ROE for Philogen S.p.A. (PHIL.MI)?
How does the current ROE for Philogen S.p.A. (PHIL.MI) compare to its historical average?